Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1
Authors:
- Shin-Ichi KawaguchiShin-Ichi Kawaguchi
- Yuhei GondaYGYuhei Gonda
- Takuya YamamotoTYTakuya Yamamoto
- Yuki SatoYSYuki Sato
- Hiroyuki ShinoharaHSHiroyuki Shinohara
- Yohsuke KobikiYKYohsuke Kobiki
- Atsuhiko IchimuraAIAtsuhiko Ichimura
- Takashi DanTDTakashi Dan
- Motohiro SonodaMSMotohiro Sonoda
- Toshio MiyataTMToshio Miyata
- Akiya OgawaAOAkiya Ogawa
- Tadayuki TsujitaTTTadayuki Tsujita
Open Access
Abstract
Induction of a series of anti-hypoxic proteins protects cells during exposure to hypoxic conditions. Hypoxia-inducible factor-α (HIF-α) is a major transcription factor that orchestrates this protective effect. To activate HIF exogenously, without exposing cells to hypoxic conditions, many small-molecule inhibitors targeting prolyl hydroxylase domain-containing protein have been developed. In addition, suppression of factor inhibiting HIF-1 (FIH-1) has also been shown to have the potential to activate HIF-α. However, few small-molecule inhibitors of FIH-1 have been developed. In this study, we synthesized a series of furan- and thiophene-2-carbonyl amino acid derivatives having the potential to inhibit FIH-1. The inhibitory activities of these compounds were evaluated in SK-N-BE(2)c cells by measuring HIF response element (HRE) promoter activity. Several furan- and thiophene-2-carbonyl amino acid derivatives inhibited FIH-1 based on correlations among the docking score of the FIH-1 active site, the chemical structure of the compounds, and biological HIF-α/HRE transcriptional activity.Keywords
This publication has 51 references indexed in Scilit:
- Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKDAmerican Journal of Kidney Diseases, 2017
- Pharmacological targeting of the HIF hydroxylases – A new field in medicine developmentMolecular Aspects of Medicine, 2016
- Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?Kidney International, 2013
- Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair ResponsesJournal of Medicinal Chemistry, 2013
- Diabetic nephropathy: a disorder of oxygen metabolism?Nature Reviews Nephrology, 2009
- Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory diseaseNature Reviews Drug Discovery, 2009
- Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?Nature Chemical Biology, 2007
- Hypoxia-Inducible Factor-1 (HIF-1)Molecular Pharmacology, 2006
- Genetic Analysis of the Role of the Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-inducible Factor (HIF) in Regulating HIF Transcriptional Target GenesJournal of Biological Chemistry, 2004
- Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic SwitchScience, 2002